University of Minnesota. Driven to Discover.
A UC–Santa Cruz team has developed a chip-based method to directly detect Ebola.
Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.
From travel-related measures to the offer of experimental vaccine, African and non-African nations take steps to control spread.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.